München, Bayern, Germany Global Life Science Ventures is the famous VC, which was founded in 1996. The company was established in Europe in Germany. The main office of represented VC is situated in the Mu00fcnchen.
The standard case for the fund is to invest in rounds with 4-5 partakers. Despite the Global Life Science Ventures, startups are often financed by Alta Partners, Gilde Healthcare, Canaan Partners. The meaningful sponsors for the fund in investment in the same round are Gilde Healthcare, Alta Partners, Forbion Capital Partners. In the next rounds fund is usually obtained by Gilde Healthcare, Van Herk Ventures, Thuja Capital.
For fund there is no match between the country of its foundation and the country of its the most frequent investments - United States. Besides, a startup needs to be aged 4-5 years to get the investment from the fund. Among the most popular fund investment industries, there are Genetics, Marketing. Among the various public portfolio startups of the fund, we may underline Agendia, Coapt Systems, Binx Health The fund has no specific favorite in a number of founders of portfolio startups. In case when startup counts 4 or 5+ of the founder, the chance for it to get the investment is meager.
The top activity for fund was in 2003. The typical startup value when the investment from Global Life Science Ventures is 5-10 millions dollars. The real fund results show that this VC is 10 percentage points more often commits exit comparing to other companies. The usual things for fund are deals in the range of 10 - 50 millions dollars. Comparing to the other companies, this Global Life Science Ventures performs on 14 percentage points more the average number of lead investments. The higher amount of exits for fund were in 2005. The fund is constantly included in less than 2 investment rounds annually.
The overall number of key employees were 2.
Related Funds
Funds with similar focus
| Fund Name | Location |
| Agro Innovation Lab Gmbh | Austria, Vienna |
| Boston Community Capital | Boston, Massachusetts, United States |
| GAN | England, London, United Kingdom |
| Gateway Partners | Central, Central Region, Singapore |
| Hidashin Innovation Partners | - |
| ID Capital | Central, Central Region, Singapore |
| INCAE Latin American Center for Entrepreneurs | - |
| Korea Credit Guarantee Fund | Daegu, South Korea, Taegu-jikhalsi |
| MCB | Mauritius, Port Louis, Port Louis |
| NetDragon Websoft | China, Foochow, Fujian |
| Nippon Technology Venture Partners | Japan, Setagaya |
| Ocmcapital | Beijing, Beijing, China |
| R-301 Capital | Lugano, Switzerland, Ticino |
| Rho West | California, Santa Monica, United States |
| Spiral Capital | Chiyoda, Japan |
| Spotlight Ventures | Kansas City, Missouri, United States |
| Summit Action | New York, New York, United States |
| Teda Venture Capital | China, Guangdong, Tianjin |
| The Boeing Company | Chicago, Illinois, United States |
| Xiangyu Hetai | Chengguan District, China, Lhasa |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Binx Health | $20M | 29 Jan 2015 | Boston, Massachusetts, United States | ||
Action Pharma | $6M | 16 Jul 2010 | Central Denmark Region | ||
Santaris Pharma | $24M | 30 Dec 2007 | Capital Region of Denmark | ||
Nitec Pharma AG | $26M | 29 Mar 2007 | Aargau, Switzerland | ||
Pieris AG | $6M | 01 Nov 2006 | Bavaria | ||
Intelligent Medical Implants Ltd | $17M | 30 Oct 2006 | Zug, Switzerland | ||
Nitec Pharma AG | $10M | 19 Oct 2005 | Aargau, Switzerland | ||
Spinal Cord Therapeutics GmbH | $15M | 19 Sep 2005 | Germany, North Rhine-Westphalia, Germany | ||
Agendia | 30 Mar 2004 | Amsterdam, North Holland, Netherlands |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Binx Health | $20M | 29 Jan 2015 | Boston, Massachusetts, United States | ||
Action Pharma | $6M | 16 Jul 2010 | Central Denmark Region | ||
Santaris Pharma | $24M | 30 Dec 2007 | Capital Region of Denmark | ||
Nitec Pharma AG | $26M | 29 Mar 2007 | Aargau, Switzerland | ||
Pieris AG | $6M | 01 Nov 2006 | Bavaria | ||
Intelligent Medical Implants Ltd | $17M | 30 Oct 2006 | Zug, Switzerland | ||
Nitec Pharma AG | $10M | 19 Oct 2005 | Aargau, Switzerland | ||
Spinal Cord Therapeutics GmbH | $15M | 19 Sep 2005 | Germany, North Rhine-Westphalia, Germany | ||
Agendia | 30 Mar 2004 | Amsterdam, North Holland, Netherlands |
